proTract® IBS â€" for the relief of symptoms of medically diagnosed irritable bowel syndrome• Is the FIRST, specifically designed Enteric Bacteria Inhibitor which targets a potential trigger of the symptoms of medically diagnosed Irritable Bowel Syndrome• Relieves a full range of symptoms thereby providing a program for controlling and maintaining Quality of Life for medically diagnosed Irritable Bowel Syndrome sufferers• It contains PCC® which is the Enteric Bacteria Inhibitor which targets a trigger of the symptoms of Irritable Bowel Syndrome• Significantly reduces the severity of Irritable Bowel Syndrome related diarrhoea, constipation, variable bowel movements, flatulants and abdominal pain• Is well tolerated and in clinical trial recorded no specific adverse events• Has been demonstrated to target a full range of symptoms providing a simple programme to help manage the symptoms of Irritable Bowel Syndrome. It thus has a significant advantage over those products which treat individual symptoms only and may have adverse side effects• Is based on an Australian scientific innovation by a public Australian company - Probiomics Ltd...proTract® IBS - Targeting a potential trigger of IBS symptoms: Research to date has not been able to identify the cause of IBS. However some studies indicate that a group of harmful bacteria, known as enteric bacteria, may be a potential trigger of the symptoms of medically diagnosed irritable bowel syndrome. One needs to take a close look at the role these microbes play in IBS. There is increasing evidence of the involvement of the intestinal microbes in IBS because there have been reports of a correlation between IBS symptoms and specific intestinal microbial profiles (including enteric bacteria) and others showing an improvement in symptoms with improving the balance of the intestinal microbes. proTract® IBS offers hope for IBS patients, since there is evidence that the specific strain in proTract® IBS can relieve symptoms of medically diagnosed IBS. PCC® Lactobacillus fermentum has been shown to reduce levels of enteric bacteria and IBS symptoms, including both diarrhoea and constipation, flatulence and bloating. These findings, combined with the suggestion that the intestinal microbes play a role in IBS, suggest that the use of proTract IBS for relief of symptoms of medically diagnosed IBS holds promise. proTract® IBS’ active ingredient, is an Enteric Bacteria Inhibitor which has been clinically demonstrated to be able to reduce the level of harmful bacteria, and also reduce the severity of a range of symptoms of medically diagnosed IBS. ...Scientific research behind proTract® for Intestinal Health Scientifically and clinically trialled to be effectiveIn evaluating the capacity of PCC® L. fermentum, the active ingredient in proTract® for Intestinal Health, to confer health benefits, it was important that scientifically valid clinical trials be conducted. These must be double-blind, placebo-controlled, randomised and ideally cross-over in design, with sufficient numbers to generate statistically relevant data. These are the kind of trials that PCC® L. fermentum has undergone. Research has shown that proTract® for Intestinal Health’s active ingredient may outperform some commonly found probiotics The active ingredient in proTract® for Intestinal Health outperforms several other commonly found probiotics, including Acidophilus, in many key factors that make a probiotic effective."http://www.vribiomedical.com.au/VRI/produc...html#intestinal ??? ( & you wouldn't have to pay customs!)Also--it contains one other probiotic--L Casei--which has been shown to help crohns patients with their abnormal reaction to enteric bacteria...I think I'm going to have to try it, & pay customs
![]()
You just never know.T-
